Kaiser Permanente is expanding its clinical trials for cancer in Sacramento, and across the state.
The National Cancer Institute has awarded a new five-year, $7.4 million grant for the trials program.
Kaiser Permanente's Roseville, Sacramento and South Sacramento hospitals participate, with nearly 900 patients involved.
"Breast cancer and lung cancer are our most common studies that we enroll patients into, but also colon, prostate," Dr. Louis Fehrenbacher said.
Fehrenbacher directs the program, which offers cutting edge treatments and explores differences between pain medications or delivery of care.
The money will fund new researchers and staff nurses.